Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adelstein

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Head & Neck|June 15, 2016
Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alonePriyanka Bhateja, Matthew C Ward, Grant H Hunter, et al.
Technology in Cancer Research & Treatment|June 5, 2003
Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective reviewDeepak Khuntia, Ratna Sajja, Mark A Chidel, et al.
Head & Neck|August 16, 2008
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapyCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classificationGregory M M Videtic, Chandana A Reddy, Samuel T Chao, et al.
Oral Oncology|May 22, 2016
Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11Matthew C Ward, David J Adelstein, Priyanka Bhateja, et al.
Archives of Pathology & Laboratory Medicine|December 1, 2018
Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer ReportingJames S Lewis, David J Adelstein, Abbas Agaimy, et al.
Head & Neck|June 6, 2015
Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancerMatthew C Ward, Priyanka Bhateja, Tobenna Nwizu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2002
Stage III non-small cell lung cancer and metachronous brain metastasesNader Moazami, Thomas W Rice, Lisa A Rybicki, et al.
Radiation Oncology (London, England)|July 11, 2013
Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomesTrevor J Bledsoe, Anisha R Noble, Grant K Hunter, et al.
American Journal of Clinical Oncology|April 7, 2007
A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneityDavid J Adelstein, Thomas W Rice, Lisa A Rybicki, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Head & Neck|June 15, 2016
Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alonePriyanka Bhateja, Matthew C Ward, Grant H Hunter, et al.
Technology in Cancer Research & Treatment|June 5, 2003
Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective reviewDeepak Khuntia, Ratna Sajja, Mark A Chidel, et al.
Head & Neck|August 16, 2008
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapyCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classificationGregory M M Videtic, Chandana A Reddy, Samuel T Chao, et al.
Oral Oncology|May 22, 2016
Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11Matthew C Ward, David J Adelstein, Priyanka Bhateja, et al.
Archives of Pathology & Laboratory Medicine|December 1, 2018
Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer ReportingJames S Lewis, David J Adelstein, Abbas Agaimy, et al.
Head & Neck|June 6, 2015
Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancerMatthew C Ward, Priyanka Bhateja, Tobenna Nwizu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2002
Stage III non-small cell lung cancer and metachronous brain metastasesNader Moazami, Thomas W Rice, Lisa A Rybicki, et al.
Radiation Oncology (London, England)|July 11, 2013
Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomesTrevor J Bledsoe, Anisha R Noble, Grant K Hunter, et al.
American Journal of Clinical Oncology|April 7, 2007
A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneityDavid J Adelstein, Thomas W Rice, Lisa A Rybicki, et al.
Pageof 11